Paper20028854
AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity.
Chresta CM and 23 others. Cancer Res, 2010. Cited by 695 papers, by iCite.
Cite this record
ConductScience Library. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Papers, record 20028854. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20028854
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Morpholines | Major topic |
| Neoplasms, Experimental | Major topic |
| Protein Kinases | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Cell Proliferation | |
| Female | |
| Humans | |
| Mice | |
| Mice, Nude | |
| Protein Kinase Inhibitors | |
| TOR Serine-Threonine Kinases | |
| Xenograft Model Antitumor Assays |
Source PubMed
Cited by444
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 695 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943233 | Biological Effects of Umbelliferone in MCF-7 Breast Cancer Cells: Integrated In Vitro and Computational Analyses. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943233 | PubMed |
| 42738804 | Exploring the Utility of ALDH1 as a Marker for the Cancer Stem Cell Population in OCCC Cell Lines. | Cells | 2026 | https://conductscience.org/library/papers/42738804 | PubMed |
| 42511704 | Advances in the Molecular Mechanisms of Cholangiocarcinoma: A Comprehensive Review of Biomarkers, Regulatory Pathways and Tumor Microenvironment Reprogramming. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511704 | PubMed |
| 42490445 | mTOR signaling contributes to system-driven rhythmic gene expression in mouse liver. | Sci Adv | 2026 | https://conductscience.org/library/papers/42490445 | PubMed |
| 42387647 | MET-associated immune prognostic signature predicts survival and guides personalized therapy in glioma. | Acta Neuropathol Commun | 2026 | https://conductscience.org/library/papers/42387647 | PubMed |
| 42310303 | Epithelial cell extrusion underlies starvation-induced cell loss in a sea anemone. | Nat Commun | 2026 | https://conductscience.org/library/papers/42310303 | PubMed |
| 42118332 | Targeting the GSK-3β/mTOR axis to overcome chemoresistance in gestational choriocarcinoma: molecular mechanisms and therapeutic opportunities. | Cancer Chemother Pharmacol | 2026 | https://conductscience.org/library/papers/42118332 | PubMed |
| 41931112 | Discovery of Autophagy Modulators that Increase I1061T NPC1 Expression and Promote Cholesterol Efflux in Niemann-Pick Type C Patient-Derived Fibroblasts. | ACS Chem Biol | 2026 | https://conductscience.org/library/papers/41931112 | PubMed |
| 41792142 | Functional genomics integration of glycolysis-related gene networks reveals prognostic biomarkers and immune microenvironment regulation in breast cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/41792142 | PubMed |
| 41615501 | Functional characterisation of Target of Rapamycin (TOR) signalling in Physcomitrella. | Plant Cell Rep | 2026 | https://conductscience.org/library/papers/41615501 | PubMed |
| 41590339 | Combination Cancer Therapy and Reference Models for Assessing Drug Synergy in Glioblastoma. | Curr Oncol | 2025 | https://conductscience.org/library/papers/41590339 | PubMed |
| 41561382 | United multi-omics and machine learning refine regulatory T cell-defined hepatocellular carcinoma subtypes. | iScience | 2026 | https://conductscience.org/library/papers/41561382 | PubMed |
| 41469379 | mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41469379 | PubMed |
| 41405991 | Liprin-α1 enhances PHLDB3 oncogenic function in colorectal cancer via activation of mTORC2-AKT1 pathway. | Cell Rep | 2026 | https://conductscience.org/library/papers/41405991 | PubMed |
| 41287790 | Unveiling disulfidptosis-linked lncRNA signatures: insights into the immune microenvironment and drug responsiveness in oral squamous cell carcinoma. | Front Genet | 2025 | https://conductscience.org/library/papers/41287790 | PubMed |
| 41170605 | Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis. | Small | 2025 | https://conductscience.org/library/papers/41170605 | PubMed |
| 41085569 | Endometrial cancer: from clinical reality to molecular treatment. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41085569 | PubMed |
| 41006635 | Nutrient-driven TOR signalling controls a chromatin-associated complex for orchestrating plant growth and stress tolerance. | Nat Plants | 2025 | https://conductscience.org/library/papers/41006635 | PubMed |
| 40747523 | Light-dark dependent changes in chloroplast and mitochondrial activity in Chlamydomonas reinhardtii. | Front Plant Sci | 2025 | https://conductscience.org/library/papers/40747523 | PubMed |
| 40715742 | Immunopharmacology of senescence: targeting the senescence-associated secretory phenotype (SASP)-a mechanism-based review. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40715742 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| EIF4EBP1 | 1978 | PubTator's text mining | https://conductscience.org/library/genes/1978 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| RPS6KB1 | 6198 | PubTator's text mining | https://conductscience.org/library/genes/6198 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20028854
GET https://conductscience.org/api/papers/v1/20028854/authors?page=2